EN HU

Highly Cited Papers

As of May/June 2026, these highly cited papers - published in 2026 - received enough citations to place them in the top 1% of different academic fields based on a highly cited threshold for a field and publication year.

1.
Mohammed, E. A. H., Fehér, M., Bársony, P., Teye-Gaga, C., Czeglédi, L., Freytag, C., Váradi, A., Ahmed, A. E. M., Pál, K.: Growth Performance, Gut Integrity and Intestinal Microbiome Responses of Juvenile Common Carp (Cyprinus carpio L.) to Probiotic and Prebiotic Supplementation.
Animals (Basel). 16 (3), 433, 2026.
Journal metrics:
Q1 Animal Science and Zoology (2025)
D1 Veterinary (miscellaneous) (2025)
2.
Virág, E., Zombori, Z., Hóvári, M., Hegedűs, G., Sass, L., Ferenc, G., Dudits, D., Posta, K.: Genotype-specific responses of maize plants to Funneliformis mosseae under drought stress: phenomic and transcriptomic insights.
Front. Plant Sci. 16, (article identifier: 1723031), 2026.
Journal metrics:
D1 Plant Science (2025)
3.
Ho, V. Q. T., Bao Tran, N., Nguyen, N., Downes, D., Arrighini, G. S., Dandamudi, M., Cardoso, R., Giorgi, J.: Oral PCSK9 inhibitors as an emerging frontier in lipid management: a meta-analysis.
J. Clin. Lipidol. 20 (1), 31-43, 2026.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine (2025)
Q1 Endocrinology, Diabetes and Metabolism (2025)
Q1 Internal Medicine (2025)
D1 Nutrition and Dietetics (2025)
4.
Giles, J. T., Charles-Schoeman, C., Buch, M. H., Dougados, M., Szekanecz, Z., Mikuls, T. R., Ytterberg, S. R., Koch, G. G., Kwok, K., Cadatal, M. J., Menon, S., Chen, Y., Diehl, A. M., Rivas, J. L., Yndestad, A., Bhatt, D. L.: Use of statins and its association with major adverse cardiovascular events with tofacitinib vs TNF inhibitors in patients with rheumatoid arthritis with and without atherosclerotic cardiovascular disease.
Ann. Rheum. Dis. 85 (1), 103-113, 2026.
Journal metrics:
D1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2025)
D1 Immunology (2025)
D1 Immunology and Allergy (2025)
D1 Rheumatology (2025)
5.
Espina, C., Ritchie, D., Riboli, E., Kromhout, H., Franceschi, S., Lansdorp-Vogelaar, I., Marteau, T. M., Bakogianni, I., Vilahur, N., Alberts, C. J., Ivanuš, U., Feliu, A., D'Souza,, E., Zeeb, H., Mitrou, G., Albreht, T., Dillner, J., Foucaud, J., Manczuk, M., Martin, M. J. M., Medema, R. H., Murray, D., Nagy, P., Nicula, F., Nyangasi, M., Steindorf, K., Tjnneland, A., Cecchini, M., Corbex, M., Stepien, M., Yared, W., Carvalho, A. L., Schüz, J., Working Groups of Scientific Experts: European Code Against Cancer 5th edition: 14 ways you can help prevent cancer.
Lancet Reg. Health-Eur. 63, 1-16, (article identifier: 101592), 2026.
Journal metrics:
D1 Health Policy (2025)
D1 Internal Medicine (2025)
D1 Oncology (2025)
D1 Public Health, Environmental and Occupational Health (2025)
6.
Agmon-Levin, N., Ignatenko, S., Gordienko, A., Cortés-Hernández, J., Narongroeknawin, P., Romanowska-Próchnicka, K., Shen, N., Ciferská, H., Kodera, M., Cheng-Chung, W. J., Leszczyński, P., Lan, J. L., Mysler, E., Wojciechowski, R., Tarr, T., Vishneva, E., Chen, Y. H., Kaneko, Y., Finzel, S., Hoi, A., Okada, M., Koolvisoot, A., Lee, S. S., Lie, D., Kaneko, H., Rojkovich, B., Sun, L., Zotkin, E., Viallard, J. F., López, B. P. M., Ghanshani, S. A., Lau, C., Avrameas, A., Sips, C., Oliver, S. J.: B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment.
Ann. Rheum. Dis. 85 (3), 476-488, 2026.
Journal metrics:
D1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2025)
D1 Immunology (2025)
D1 Immunology and Allergy (2025)
D1 Rheumatology (2025)
7.
Steindorff, A. S., Cai, F. M., Ding, M., Emri, T., Miskei, M., Pócsi, I., Druzhinina, I. S.: Phenogenomics reveals the ecology and evolution of Trichoderma fungi for sustainable agriculture.
Nat Microbiol. 11 (3), 815-831, 2026.
Journal metrics:
D1 Applied Microbiology and Biotechnology (2025)
D1 Cell Biology (2025)
D1 Genetics (2025)
D1 Immunology (2025)
D1 Microbiology (2025)
D1 Microbiology (medical) (2025)
8.
Vleugels, R. A., Paik, J. J., Bauer Ventura, I., Mangold, A. R., Gandiga, P. C., Haemel, A., Chinoy, H., Hussain, Y. M., Sivakumar, K., Griger, Z., Lee, E. B., Bozán, F., Hsu, C. Y., Femia, A., Dimachkie, M. M., Min, M. S., Mozaffar, T., Charles-Schoeman, C., Fernandez, D. R., Onajin, O., Campanilho-Marques, R., Marder, G., Ernste, F., Schiopu, E., Sluzevich, J., Pearson, D., Lindsey, S., Luggen, M., Bubb, M. R., Boh, E., Maganti, R., Heinlen, L., Shaw, K. S., Cascino, M. D., Mudd, P. N., Vencovsky, J., Fernandez, A. P., Fiorentino, D., Christopher-Stine, L., Werth, V. P., Aggarwal, R., VALOR Investigators: A Phase 3 Trial of Brepocitinib in Dermatomyositis.
N. Engl. J. Med. 394 (19), 1883-1893, 2026.
Journal metrics:
D1 Medicine (miscellaneous) (2025)
DEENK University of Debrecen
© 2012 University of Debrecen